M&A, Weight Loss, and Tesla

from Bloomberg Intelligence · host Bloomberg

Ted Smith, co-founder at Union Square Advisors, joins to discuss expected M&A activity in 2024. Sam Fazeli, Head of Euro Research and Pharma Analyst at Bloomberg Intelligence, discusses Pfizer’s miss and weight loss drug developments, and outlooks for those drugs in 2024. Steve Man, Global Auto Market Research Leader at Bloomberg Intelligence, joins to break down Tesla’s recall and outlook for the company. Mike Green, Portfolio Manager and Chief Strategist at Simplify Asset Management, joins to discuss markets and investing. Hosted by Paul Sweeney and Bailey Lipschultz.See omnystudio.com/listener for privacy information.

NOW PLAYING

0:00 37:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Bloomberg Intelligence?

This episode is 37 minutes long.

When was this Bloomberg Intelligence episode published?

This episode was published on December 13, 2023.

What is this episode about?

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Bloomberg Intelligence episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!